Ampelopsin

Ampelopsin

SCHEMBL29462401

O=C1c2c(O)cc(O)cc2OC(c2cc(O)c(O)c(O)c2)C1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYNJ2 O15056 3/20 1.00
SOST Q9BQB4 2/20 1.00
APP P05067 1/20 1.00
RECQL P46063 4/20 0.75
KDM4E B2RXH2 2/20 0.75
MAPT P10636 2/20 0.75
ALOX15 P16050 2/20 0.75
HSD17B10 Q99714 2/20 0.75
MEN1 O00255 1/20 0.75
KMT2A Q03164 1/20 0.75
POLB P06746 1/20 0.75
GAA P10253 1/20 0.75
CYP1A2 P05177 1/20 0.75
CYP3A4 P08684 1/20 0.75
ALOX12 P18054 1/20 0.75
NFKB1 P19838 1/20 0.75
MAPK1 P28482 1/20 0.75
HIF1A Q16665 1/20 0.75
XDH P47989 2/20 0.74
TDP1 Q9NUW8 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ampelopsin SCHEMBL134531 1.00 SYNJ2 (1.00) SYNJ2SOSTAPPRECQLKDM4E
Ampelopsin SCHEMBL22750858 1.00 SYNJ2 (1.00) SYNJ2SOSTAPPRECQLKDM4E
Ampelopsin SCHEMBL29138729 1.00 SYNJ2 (1.00) SYNJ2SOSTAPPRECQLKDM4E
Ampelopsin SCHEMBL29362330 1.00 SYNJ2 (1.00) SYNJ2SOSTAPPRECQLKDM4E
Ampelopsin SCHEMBL723736 1.00 SYNJ2 (1.00) SYNJ2SOSTAPPRECQLKDM4E
Ampelopsin SCHEMBL134532 1.00 SYNJ2 (1.00) SYNJ2SOSTAPPRECQLKDM4E
Ampelopsin SCHEMBL544092 0.99 SYNJ2 (0.97) SYNJ2SOSTAPPRECQLKDM4E
Ampelopsin SCHEMBL28158121 0.93 SOST (0.87) SYNJ2SOSTAPPRECQLKDM4E
SCHEMBL15545301 0.91 SOST (0.83) SYNJ2SOSTAPPRECQLKDM4E
SCHEMBL21587452 0.91 SYNJ2 (0.82) SYNJ2SOSTAPPRECQLKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023219526-A1 MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT PROKIN MILAN (RS) 2023-11-16 WO claimed
WO-2023064318-A1 BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE Natural Extraction Systems, LLC (US) 2023-04-20 WO claimed
WO-2022182527-A1 COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS Natural Extraction Systems, LLC (US) 2022-09-01 WO claimed
WO-2025043213-A2 THERAPEUTIC COMPOUNDS AND METHODS UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2025-02-27 WO disclosed
WO-2024189607-A1 METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT DIDENKO KIRILL (MX) 2024-09-19 WO disclosed
WO-2023219526-A1 MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT PROKIN MILAN (RS) 2023-11-16 WO disclosed
WO-2023064318-A1 BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE Natural Extraction Systems, LLC (US) 2023-04-20 WO disclosed
CN-110183431-B Compound for treating or preventing liver diseases 江苏新元素医药科技有限公司 2023-04-11 CN disclosed
CN-113121486-B Single-configuration extraction method of dihydromyricetin 宁波大学 2022-07-15 CN disclosed
CN-109369596-B Preparation method of taxifolin 陕西嘉禾生物科技股份有限公司 2022-05-17 CN disclosed
CN-109369593-B Preparation method of kaempferol 陕西嘉禾生物科技股份有限公司 2022-04-08 CN disclosed
CN-114223762-A Racemization protection method of dihydromyricetin 宁波大学 2022-03-25 CN disclosed